Warning letter
Greenbrier International, Inc dba Dollar Tree: warning letter of Nov 6, 2019
FDA warning letter 574706 · Center for Drug Evaluation and Research
Key facts
| Reference number | 574706 |
|---|---|
| Company | Greenbrier International, Inc dba Dollar Tree |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Nov 6, 2019 |
| Posted date | Nov 14, 2019 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 211.84(d)(1), 211.165(a), 211.165(b) |
| Inspection city | Chesapeake |
| Inspection ZIP | 23320-1604 |
| Inspection start date | Jan 14, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: